The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 3, 2000, Pages 425-431

  Ferger, B ^a   Teismann, P ^a   Earl, C D ^a   Kuschinsky, K ^a   Oertel, W H ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hydroxyl radicals; MPTP; Neuroprotection; Parkinson's disease; PBN; Radical scavenger; Salicylate trapping

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BENZOIC ACID DERIVATIVE; DOPAMINE; HYDROXYL RADICAL; N TERT BUTYL ALPHA PHENYLNITRONE; SALICYLIC ACID; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG EFFECT; LOCOMOTION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SPIN TRAPPING; SURVIVAL RATE; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; DOPAMINE; FREE RADICAL SCAVENGERS; HYDROXYL RADICAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; NITROGEN OXIDES;

EID: 0033956502     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00229-4     Document Type: Article

References (42)

1. Aubin N., Curet O., Deffois A., Carter C. Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J. Neurochem. 71:1998;1635-1642.
2. Buxton G.U., Greenstock C.L., Helman W.P., Ross A.B. Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals. Phys. Chem. Ref. Data. 17:1988;513-886.
3. Cadenas E., Boveris A., Ragan C.I., Stoppani A.O.M. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef heart mitochondria. Arch. Biochem. Biophys. 180:1977;248-257.
4. Cao X., Phillis J.W. α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644:1994;267-272.
5. Carney J.M., Floyd R.A. Protection against oxidative damage to CNS by α-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents. A novel series of nonlipid free radical scavengers J. Mol. Neurosci. 3:1991;47-57.
6. Chen G., Bray T.M., Janzen E.G., McCay P. Excretion, metabolism and tissue distribution of a spin trapping agent, α-phenyl-N-tert-butylnitrone (PBN) in rats. Free Radic. Res. Commun. 9:1990;317-323.
7. Cheng H.-Y., Liu T., Feuerstein G., Barone F.C. Distribution of spin-trapping compounds in rat blood and brain. In vivo microdialysis determination Free Radic. Biol. Med. 14:1993;243-250.
8. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
9. Ferger B., van Amsterdam C., Seyfried C., Kuschinsky K. Effects of α-phenyl-tert-butylnitrone and selegiline on hydroxyl free radicals in rat striatum produced by local application of glutamate. J. Neurochem. 70:1998;276-280.
10. Floyd R.A., Carney J.M. Free radical damage to protein and DNA. Mechanisms involved and relevant observations on brain undergoing oxidative stress Ann. Neurol. 32:1992;22-27.
11. Floyd R.A., Watson J.J., Wong P.K. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate products. J. Biochem. Biophys. Methods. 10:1984;221-235.
12. Folbergrova J., Zhao Q., Katsura K.-I., Siesjö B.K. N-tert-butyl-α-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl. Acad. Sci. USA. 92:1995;5057-5061.
13. Fredriksson A., Eriksson P., Archer T. MPTP-induced deficits in motor activity. Neuroprotective effects of the spintrapping agent, α-phenyl-tert-butyl-nitrone (PBN) J. Neural. Transm. 104:1997;579-592.
14. Gerlach M., Riederer P. Animal models of Parkinson's disease. An empirical comparison with phenomenology of the disease in man J. Neural. Transm. 103:1996;987-1041.
15. Götz M.E., Künig G., Riederer P., Youdim M.B.H. Oxidative stress. Free radical production in neural degeneration Pharmacol. Ther. 63:1994;37-122.
16. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science. 274:1996;1383-1385.
17. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
18. Hasegawa E., Takeshige K., Ioshi T., Murai Y., Minakami S. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170:1990;1049-1055.
19. Hensley K., Pye Q.N., Maidt M.L., Stewart C.A., Robinson K.A., Jaffrey F., Floyd R.A. Interaction of α-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J. Neurochem. 71:1998;2549-2557.
20. Herrero A., Barja G. Sites and mechanisms responsible for the low rate of free radical production of heart mitochondria in the long-lived pigeon. Mech. Ageing Dev. 98:1997;95-111.
21. Janzen E.G., West M.S., Poyer J.L. Comparison of the antioxidant activity of PBN with hindered phenols in initiated rat liver microsomal peroxidation. Asada K., Yoshikawa T. Frontiers of reactive oxygen species in biology and medicine. 1994;431-434 Elsevier Science, Amsterdam.
22. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13(Suppl. 1):1998;24-34.
23. Karam L.R., Bergtold D.S., Simic M.G. Biomarkers of free radical OH radical damage in vivo. Free Radic. Res. Commun. 12-13:1991;11-16.
24. Klivenyi P., Matthews R.T., Wermer M., Yang L., MacGarvey U., Becker D.A., Natero R., Beal M.F. Azulenyl nitrone spin traps protect against mPTP neurotoxicity. Exp. Neurol. 152:1998;163-166.
25. Knight J.A. Reactive oxygen species and the neurodegenerative disorders. Ann. Clin. Lab. Sci. 27:1997;11-25.
26. Kotake Y., Janzen E.G. Decay and fate of the hydroxyl radical adduct of α-phenyl-N-tert-butylnitrone in aqueous media. J. Am. Chem. Soc. 113:1991;9503-9506.
27. Kotake Y., Sang H., Miyajima T., Wallis G.L. Inhibition of NF-kappaB, iNOS mRNA, COX-2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim. Biophys. Acta. 14448:1998;77-84.
28. Lancelot E., Revaud M.-L., Boulu R.G., Plotkine M., Callebert J. alpha-phenyl-tert-butylnitrone attenuates excitotoxicity in rat striatum by preventing hydroxyl radical accumulation. Free Radic. Biol. Med. 7:1997;1031-1034.
29. Matthews R.T., Klivenyi P., Mueller G., Yang L., Wermer M., Thomas C.E., Beal M.F. Novel free radical spintraps protect against malonate and MPTP neurotoxicity. Exp. Neurol. 157:1999;120-126.
30. Nakao N., Grasbon-Frodl E.M., Widner H., Brundin P. Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience. 73:1996;185-200.
31. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
32. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA. 87:1990;5144-5147.
33. Przedborski S., Jackson-Lewis V., Yokoyama R., Sibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
34. Przedborski S., Kostic V., Jackson-Lewis V., Naini S., Simonetti S., Fahn S., Carlson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667.
35. Schulz J.B. Henshaw, D. R.; Matthews, R. T.; Beal, M. F.: Coenzyme Q. 10(and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp. Neurol. 132):1995;279-283.
36. Schulz J.B., Henshaw D.R., Siwek D., Jenkins B.G., Ferrante R.J., Cipolloni P.B., Kowall N.W., Rosen B.R., Beal M.F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64:1995;2239-2247.
37. Schulz J.B., Matthews R.T., Muqit M.M.K., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
38. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:1996;83-106.
39. Smith T.S., Bennett Jr J.P. Mitochondrial toxins in models of neurodegenerative diseases. I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions Brain Res. 765:1997;183-188.
40. Sriram K., Pai K.S., Boyd M.R., Ravindranath V. Evidence for generation of oxidative stress in brain by MPTP. In vitro and in vivo studies Brain Res. 749:1997;44-52.
41. Thomas C.E., Ohlweiler D.F., Taylor V.L., Schmidt C. Radical trapping and inhibition of iron-dependent CNS damage by cyclic nitrone spin traps. J. Neurochem. 68:1997;1173-1182.
42. Zhao Q., Pahlmark K., Smith M.-L., Siesjö B.K. Delayed treatment with the spin trap α-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol. Scand. 152:1994;349-350.